Immune Response

Low CTDNEP1 Tied to Poorer Outcomes in Pancreatic Cancer, Study Finds

Analysis of 184 TCGA/Pan-Cancer Atlas cases finds reduced CTDNEP1 expression aligns with immune suppression in pancreatic tumors.